NEW YORK, Nov. 5, 2025 /PRNewswire/ — T. Rowe Price OHA Select Private Credit Fund (the “Company” or “OCREDIT”) today reported financial results and total distributions of $0.69 per share for the quarter ended September 30, 2025. As private credit remains a key driver of financing solutions within credit markets, OCREDIT closed the third quarter with the… Continue reading T. ROWE PRICE OHA SELECT PRIVATE CREDIT FUND ANNOUNCES SEPTEMBER 30, 2025 FINANCIAL RESULTS AND DECLARED TOTAL DISTRIBUTIONS OF $0.69 PER SHARE IN Q3 2025
Category: Official Press Release
Centrus Reports Third Quarter 2025 Results
Net income of $3.9 million on $74.9 million in revenue, compared to net loss of $5.0 million on $57.7 million in revenue in Q3 2024 Strengthened balance sheet and increased unrestricted cash balance to $1.6 billion by closing upsized and oversubscribed $805 million convertible senior notes offering Secured U.S. government waivers for 2026 and 2027… Continue reading Centrus Reports Third Quarter 2025 Results
Sun Life increases Common Share dividend and declares dividends on Preferred Shares payable in Q4 2025
TORONTO, Nov. 5, 2025 /PRNewswire/ – The Board of Directors (“the Board”) of Sun Life Financial Inc. (“the Company”) (TSX: SLF) (NYSE: SLF) today announced that a dividend of $0.92 per share on the common shares of the Company has been declared, payable December 31, 2025 to shareholders of record at the close of business on… Continue reading Sun Life increases Common Share dividend and declares dividends on Preferred Shares payable in Q4 2025
PIH Health Expands Robotic Surgery Program with Second da Vinci 5 System
WHITTIER, Calif., Nov. 5, 2025 /PRNewswire/ — PIH Health has introduced a second da Vinci 5 robotic surgical system, now in use at PIH Health Good Samaritan Hospital in Los Angeles. The hospital completed its first surgery with the new system on November 5, 2025. Jiah Jang DO, PIH Health affiliated surgeon, performed the first… Continue reading PIH Health Expands Robotic Surgery Program with Second da Vinci 5 System
RUSSEL METALS ANNOUNCES 2025 THIRD QUARTER RESULTS
TORONTO, Nov. 5, 2025 /PRNewswire/ – Russel Metals Inc. (TSX: RUS) announces financial results for three months ended September 30, 2025. Revenues of $1.2 Billion; EBITDA of $75 Million; EPS of $0.63 $14 million of Share Buybacks and $24 million of Dividends Strong Capital Structure with Liquidity of $600 Million Year to Date Annualized Return… Continue reading RUSSEL METALS ANNOUNCES 2025 THIRD QUARTER RESULTS
Sun Life Reports Third Quarter 2025 Results
Sun Life Financial Inc. (“SLF Inc.”), its subsidiaries and, where applicable, its joint ventures and associates are collectively referred to as “the Company”, “Sun Life”, “we”, “our”, and “us”. We manage our operations and report our financial results in five business segments: Asset Management, Canada, United States (“U.S.”), Asia, and Corporate. The information in this… Continue reading Sun Life Reports Third Quarter 2025 Results
Vermilion Energy Inc. Reports Strong Q3 2025 Results, Lowers 2025 Cost Guidance, Releases 2026 Budget and Announces Planned 4% Dividend Increase
CALGARY, AB, Nov. 5, 2025 /PRNewswire/ – Vermilion Energy Inc. (“Vermilion”, “We”, “Our”, “Us” or the “Company”) (TSX: VET) (NYSE: VET) is pleased to report operating and condensed financial results for the three and nine months ended September 30, 2025. The unaudited interim financial statements and management discussion and analysis for the three and nine months ended September 30,… Continue reading Vermilion Energy Inc. Reports Strong Q3 2025 Results, Lowers 2025 Cost Guidance, Releases 2026 Budget and Announces Planned 4% Dividend Increase
Vanda Pharmaceuticals Announces Participation in the Stifel 2025 Healthcare Conference
WASHINGTON, Nov. 5, 2025 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the Stifel 2025 Healthcare Conference in New York City on Wednesday, November 12, 2025. A corporate presentation is scheduled for 4:40 p.m. Eastern Time. The corporate presentation given at the Stifel conference may be accessed… Continue reading Vanda Pharmaceuticals Announces Participation in the Stifel 2025 Healthcare Conference
Stoneridge Reports Third Quarter 2025 Results
Continued Progress on Key Operational Priorities Announcing MirrorEye® OEM Program Award with an Additional Truck Manufacturer Announcing Leak Detection Module and Park Lock Actuator Program Awards 2025 Third Quarter Results Sales of $210.3 million Gross profit of $42.8 million (20.3% of sales) Adjusted gross profit of $43.7 million (20.8% of sales) Operating loss of $(3.3)… Continue reading Stoneridge Reports Third Quarter 2025 Results
OceanaGold Reports Third Quarter 2025 Results
(All financial figures in United States dollars unless otherwise stated) On track to deliver full year guidance with strong Q4 advancing as planned Free Cash Flow† of $94 million with $335 million of cash and no debt at quarter end Share buyback program increased by 75% to $175M, expected to be completed by year end… Continue reading OceanaGold Reports Third Quarter 2025 Results